Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5568_Библиотеки_им_академика_М_И_Перельмана
.pdf
438 Index
Magnesium oxide coating
(MgO coating), 136. See also
Octacalcium coatings
corrosion resistance, 141–143
immersion behavior, 144–148
PLA composite coating film, 148–149
preparation and characterization
anodic polarization behavior, 136–138
on Mg alloy, 138–140
Magnesium stearate (MgSt), 320
Manganese (Mn), 408–409
Manganese hydrogen phosphate (MnHPO
4
411
Manganese phosphate (MnPO
), 411
4
applications, 424–425
biocompatible coating, 416
advantages and disadvantages,
423–424
on Mg alloy AZ91D, 419f
Mg alloys retard corrosion, 416–423
preparation, 416–423
MAO coatings. See Micro-arc oxidation
coatings
Mazak Quick Turn-10 Turning Center,
107, 108f
MBs. See Microbands
MD. See Molecular dynamic
MEM. See Minimum essential medium
Metallic magnesium, 83, 355
Metals, 151–152
MgO coating. See Magnesium oxide coating
Micro-arc oxidation coatings (MAO
coatings), 10, 29, 135, 176–179,
193, 235, 275, 310–311, 343, 361.
See also Plasma electrolytic
oxidation (PEO)
characteristics and architecture, 236–237
MAO-coated Mg corrosion resistance
additives, 244–249, 245t–248t
ceramic particles incorporation, 249–250
choice of electrolytes, 237–239
multifunctional coating approach,
255–260
postsealing treatments, 250–255,
252t–254t
pretreatment, 243–244
process parameters and conditions,
239–242
Mg surface modification, 236
porous structure advantages and limitations,
237
surface morphology of, 241f
mCT. See Microfocus computed tomography
Micro-plasma oxidation. See Micro-arc
oxidation (MAO)
Microbands (MBs), 393–394
Microfocus computed tomography (mCT),
221–
222
Micropores, 197–198
Microstructure characterization, 349–350
Minimum essential medium (MEM),
),
163–164, 413
Molecular dynamic (MD), 399–400
monofunctional poly(ethylene glycol)
(mPEG), 359
mPEG. See monofunctional poly(ethylene
glycol)
Multifunctional coating approach, 255–260
N
nano-hydroxyapatite (nHAP), 361, 371
Nanoparticle (NP), 255–256
Natural biomaterial-based coatings, 301
Nerve guidance conduit (NGC), 338–339,
340f
Nerve regenerative devices, 338–339
Neural applications
electrode microarrays for, 337f
magnesium for, 339–341
Neural prosthetic devices, 335–338
Neural regeneration, 338–339
Neurological injuries treatment, 335
NGC. See Nerve guidance conduit
Nitric acid (HNO
), 416
3
Nontoxicity, 28
O
OCP. See Octacalcium phosphate; Open
current potential
Octacalcium coatings. See also Magnesium
oxide coating (MgO coating)
corrosion morphology of substrate Mg
alloy, 71–73
CSD, 60–61
formation and growth mechanism, 66–68
after immersion, 73–74
influence of deposition conditions, 61–63
Index 439
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
magnesium ion release behaviour, 70–71
Mg/Mg alloy substrate influence, 63–66
morphology, crystal structure and
composition, 68–69
Octacalcium phosphate (OCP), 59, 164
Open current potential (OCP), 33
Orthopaedic devices, 75
Osseointegration, 196–197
Oxidizing accelerators, 32
P
PA. See Phytic acid; Plasma arc
Paclitaxel (PTX), 256
PAN. See Polyacrilonitrile
PANi. See Polyaniline
Particle additions, 207–210
PBS. See Phosphate-buffered saline
PCL. See Poly-3-caprolactone;
Polycaprolactone
PEDOT. See Poly(3,4-
ethylenedioxythiophene)
PEI. See Polyetherimide
PEO. See Plasma electrolytic oxidation
PEPVD. See Plasma-enchased physical
vapour deposition
PGA. See Polyglycolic acid
pH value, 31
PHB. See Polyhydroxybutyrate
Phosphate coating
formation process, 32–37
surface microstructure and composition, 37
Phosphate composite films
by AD, 315–318
by EPD, 310–313
Phosphate-buffered saline (PBS), 161,
310–311
Phosphating process, 29
accelerator, 32
anticorrosion agent, 31
depletion of bath constituents, 31
dihydric phosphate, 30
dilute phosphoric acid-based solutions, 30
hydrogen gas bubbles, 30
magnesium alloys, 29–30
pH value, 31
Physical vapour deposition (PVD), 81
controlling material degradation, 90–91
chamber base pressure, 95–97
in situ cleaning, 91–95
vapour source, 97–98
fi
lm structure, 87–90
and limitations, 81–83
magnesium alloys, 83–87
Phytic acid (PA), 302, 302f
coated on WE43 alloys, 302–307
potentiodynamic polarization parameters,
305t
PIIID. See Plasma immersed ion
implantation and deposition
PLA. See Polylactic acid
Plasma anodizing. See Micro-arc oxidation
(MAO)
Plasma arc (PA), 381–382
Plasma electrolytic anodization (PEO).
See Micro-arc oxidation coatings
(MAO coatings)
Plasma electrolytic oxidation (PEO), 10, 29,
135, 193, 369–371. See also
Micro-arc oxidation (MAO)
applications, 225–226
in biomedical applications, 214
biocompatibility, 220–221
corrosion, 217–220
mechanical properties, 214–216
in vivo testing, 221–225
coating requirements for biomedical
applications, 196–199, 199f
composition, microstructure, and
properties, 200
electrolyte composition, 204–207
energy input, 200–204
particle additions, 207–210
duplex treatments, 210–214
principles, 193–196
Plasma immersed ion implantation and
deposition (PIIID), 84
Plasma spray (PS), 380
Plasma-assisted coatings, 85
Plasma-enchased physical vapour deposition
(PEPVD), 84
PLG. See Poly(lactide-co-glycolide)
PLGA. See Polyglycolic acid (PGA)
PLLA. See Poly(L-lactic acid)
Poly-3-caprolactone (PCL), 343
Poly(1,3-trimethylene carbonate) (PTMC),
359, 361, 366
440 Index
Poly(3,4-ethylenedioxythiophene)
(PEDOT), 342–343
Poly(D, L-lactide-co-glycolide) (DLPLG),
359
Poly(DL-lactide-co-glycolide). See
Polyglycolic acid (PGA)
Poly(L-lactic acid) (PLLA), 174, 256
Poly(lactide-co-glycolide) (PLG), 357
Poly(vinyl acetate) (PVA), 276
Polyacrilonitrile (PAN), 13
Polyaniline (PANi), 342–343
Polycaprolactone (PCL), 301, 356–357,
356f
Polyetherimide (PEI), 13, 214, 342
Polyglycolic acid (PGA), 197–198,
255–256, 301, 343, 356–357,
356f
Polyhydroxybutyrate (PHB), 356–357,
356f, 359
Polylactic acid (PLA), 136, 197–198, 301,
356–357, 356f
Polylactic-co-glycolic acid. See Polyglycolic
acid (PGA)
Polymer biocompatibility, 360–362
Polymer coating, 342
biodegradable polymers, 343
combination, 343
conductive polymers, 342–343
Polymers degradation mechanism, 357–359
Polypyrrole (PPy), 342–343
Polythiophenes (PT), 342–343
Polyvinylidene difluoride (PVDF), 13
Porous coatings, 391f
Postdeposition procedures, 157–161
Postsealing treatments, 250–255, 252t–254t
Potentiodynamic polarization, 142–143,
142f
PPy. See Polypyrrole
PRAC. See European Pharmacovigilance
Risk Assessment Committee
Predeposition procedures, 157–161
PS. See Plasma spray
PT. See Polythiophenes
Poly(1,3-trimethylene carbonate) (PTMC)
PTX. See Paclitaxel
Pulse frequency, 241
PVA. See Poly(vinyl acetate)
PVD. See Physical vapour deposition
PVDF. See Polyvinylidene difluoride
R
Reactive ion beam sputter deposition
(RIBSD), 96
Reactive ion beam-assisted deposition
(RIBAD), 84
Regenerative electrode, 338f
Relative growth rate (RGR), 42–43
Residual stresses, 106–107
RGR. See Relative growth rate
Rod-like nano hydroxyapatite (RNHA), 259
S
S-K model. See Stranski-Krastanov model
SA. See Stearic acid
SAXD. See Small-angle X-ray diffraction
SBF. See Simulated body fluid
Scanning electron microscopy (SEM),
107, 350
FEG, 317–318
samples after immersion in Hank’s
balanced salt solution, 279
surfaces of HA, 318f
Self-healing processes, 14
SEM. See Scanning electron microscopy
Severe plastic deformation (SPD), 107
SFE. See Stacking fault energy
Simulated body fluid (SBF), 23–24
composition, 14t
long-term immersing test, 136
PLA on pure magnesium, 362
pre-treated substrate metal immersion, 61
Simulated intestinal fluid (SIF), 218–220
Small-angle X-ray diffraction (SAXD),
36–37
SMAT. See Surface mechanical attrition
treatment
Sol-gel coating, 255
Sol–gel preparation, 167–168
SPD. See Severe plastic deformation
Spin coating, 174, 345–346
Spray coating, 174–175, 346
Stacking fault energy (SFE), 397–399
Stearic acid (SA), 293, 319
coating on magnesium, 320–323
Stern–Geary equation, 141
–142
Stranski-Krastanov model (S-K model),
87–88
Stress shielding effect, 214–215
Index 441
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
Strontium (Sr), 221, 408–409
Strontium phosphate (SrPO
), 409–411
4
applications, 424–425
biocompatible coating, 412
advantages and disadvantages,
415–416
Mg inhibit initial biodegradation,
412–413
preparation, 412–413
Strontium titanate (SrTiO
), 409–411
3
Substrate material, 81–82
Superhydrophobic coatings on Mg alloys,
289–293, 290t–291t
Surface coating, 59
Surface degradation polymers, 359
Surface mechanical attrition treatment
(SMAT), 104, 393–394, 397–399
Surface modification
on magnesium alloys, 301
BSA modification, 327–328
chitosan modification, 307–318
gelatin modification, 323–327
PA modification, 302–307
SA modification, 319–323
techniques, 390–391
Surface morphology, 39–42
Surface roughening, 291–292
Surface treatment, 380
for Mg alloys, 380–382
T
TA value. See Total acid value
TCP. See Tissue culture plastic
Thermal spray, 381–382
Time-of-flight secondary ion mass
spectrometry (ToF-SIMS), 328
Tissue culture plastic (TCP), 392
Titanium (Ti), 407
Titanium oxide (TiO
), 411–412
2
TMMOS. See Trimethylmethoxysilane
ToF-SIMS. See Time-of-flight secondary
ion mass spectrometry
Total acid value (TA value), 31
Trimethylmethoxysilane (TMMOS),
289–291
TWA. See Twin wire-arc spray
Twin wire-arc spray (TWA), 380
U
U.S. Food and Drug Administration (FDA),
339, 357
V
Vapour source, 97–98
Volmer-Weber model (V-W model), 87
W
Wear protection coatings, 387–390
Wet chemical precipitation, 163–167
X
X-ray diffraction (XRD), 7, 63–65, 136,
138–139, 311
X-ray photoelectron spectroscopy (XPS), 7,
14, 69
Z
Zener-Hollomon parameter, 110–111
Zinc (Zn), 408–409
Соседние файлы в папке Библиотека им академика М.И. Перельмана